Skip to main content
SpringerLink
Log in

Neurorehabilitation in Neuro-Oncology

  • Chapter
  • First Online:
Book cover Neurorehabilitation in Neuro-Oncology

Abstract

Due to both the improved survival and the greater interest in enhancing the quality of patient’s residual life, rehabilitation has gained a growing role in the management of brain tumour (BT) patients in the last decades. BT patients can experience a wide range of symptoms and functional limitations, such as reduced mobility, cognitive and psychological problems, difficulties with self-care, relationship and work issues. As for other diseases/impairments, also disabilities caused by BT can be expressed within the conceptual framework of the International Classification of Functioning, Disability and Health (ICF) to describe health and the multidimensional health-related concerns of persons. Ultimately, all these symptoms and functional limitations can result in reduced ability in daily life activities and in performing (or maintaining) usual family and social roles, with a substantial impact on quality of life. Neuro-oncological rehabilitation refers to the process of assisting a person who has become disabled as a result of tumour (or therapies) to improve symptoms, and maximize functional independence, activity and participation, within the limits of the persisting impairment. Literature evidence suggests that despite rehabilitation in BT patients is not well established as it is for patients with other neurological conditions, symptoms and disabilities may be addressed through a “multidisciplinary rehabilitation” delivered in all the stages of the disease, by a team of different healthcare professionals working in an organized manner.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McFaline-Figueroa JR, Lee EQ. Brain tumors. Am J Med. 2018;22:pii:S0002-9343(18)30031-7.

    Google Scholar 

  2. Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gonçalves A. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 2012;32(11):4655–62.

    PubMed  Google Scholar 

  3. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, et al. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012;48:1532–42.

    Article  PubMed  Google Scholar 

  4. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17(Suppl.4):iv1–62.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sim HW, Morgan ER, Mason WP. Contemporary management of high-grade gliomas. CNS Oncol. 2018;7(1):51–65.

    Article  CAS  PubMed  Google Scholar 

  6. Ostrom QT, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan JS. Epidemiology of intracranial gliomas. Prog Neurol Surg. 2018;30:1–11.

    Article  PubMed  Google Scholar 

  7. Vargo M. Brain tumor rehabilitation. Am J Phys Med Rehabil. 2011;90(Suppl):S50–62.

    Article  PubMed  Google Scholar 

  8. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.

    Article  PubMed  Google Scholar 

  9. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80:346–50.

    Article  CAS  PubMed  Google Scholar 

  10. Schiffbauer H, Ferrari P, Rowley HA, Berger MS, Roberts TP. Functional activity within brain tumours: a magnetic source imaging study. Neurosurgery. 2001;49:1313–20.

    Article  CAS  PubMed  Google Scholar 

  11. Duffau H. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol. 2005;4(8):476–86.

    Article  PubMed  Google Scholar 

  12. Russo M, Villani V, Taga A, Genovese A, Terrenato I, Manzoni GC, et al. Headache as a presenting symptom of glioma: a cross-sectional study. Cephalalgia. 2017;38(4):730–5.

    Google Scholar 

  13. Politsky JM. Brain tumor-related epilepsy: a current review of the etiologic basis and diagnostic and treatment approaches. Curr Neurol Neurosci Rep. 2017;17(9):70.

    Article  PubMed  CAS  Google Scholar 

  14. Vecht C, Royer-Perron L, Houillier C, Huberfeld G. Seizures and anticonvulsants in brain tumours: frequency, mechanisms and anti-epileptic management. Curr Pharm Des. 2017;23(42):6464–87.

    Article  CAS  PubMed  Google Scholar 

  15. Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ. Symptom management and quality of life in glioma patients. CNS Oncol. 2014;3(1):37–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hervey-Jumper SL, Berger MS. Role of surgical resection in low- and high-grade gliomas. Curr Treat Opt Neurol. 2014;16:284.

    Article  Google Scholar 

  17. Brown TJ, Brennan MC, Li M, Church EW, Brandmeir N, Rakszawski KL, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016;2:1460–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lara-Velazquez M, Al-Kharboosh R, Jeanneret S, Vazquez-Ramos C, Mahato D, Tavanaiepour D, et al. Advances in brain tumor surgery for glioblastoma in adults. Brain Sci. 2017;7(12):166.

    Article  PubMed Central  CAS  Google Scholar 

  19. Asher A, Fu JB, Bailey C, Hughes JK. Fatigue among patients with brain tumors. CNS Oncol. 2016;5(2):91–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kirshblum S, O’Dell MW, Ho C, Barr K. Rehabilitation of persons with central nervous system tumors. Cancer. 2001;92:1029–38.

    Article  CAS  PubMed  Google Scholar 

  21. Behrend SW. Patients with primary brain tumors. Oncol Nurs Forum. 2014;41(3):335–6.

    Article  PubMed  Google Scholar 

  22. Argyriou AA, Assimakopoulos K, Iconomou G, Giannakopoulou F, Kalofonos HP. Either called “chemobrain” or “chemofog,” the long-term chemotherapy-induced cognitive decline in cancer survivors is real. J Pain Symptom Manage. 2011;41(1):126–39.

    Article  PubMed  Google Scholar 

  23. Bower JE. Treating cancer-related fatigue: the search for interventions that target those most in need. J Clin Oncol. 2012;30(36):4449–50.

    Article  PubMed  Google Scholar 

  24. de Raaf PJ, de Klerk C, van der Rijt CC. Elucidating the behavior of physical fatigue and mental fatigue in cancer patients: a review of the literature. Psychooncology. 2013;22(9):1919–29.

    Article  PubMed  Google Scholar 

  25. World Health Organization. International classification of functioning, disability, and health (ICF). Geneva: WHO; 2001.

    Google Scholar 

  26. Bornbaum CC, Doyle PC, Skarakis-Doyle E, Theurer JA. A critical exploration of the international classification of functioning, disability, and health (ICF) framework from the perspective of oncology: recommendations for revision. J Multidiscip Healthc. 2013;6:75–86.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Jette DU, Halbert J, Iverson C, Miceli E, Shah P. Use of standardized outcome measures in physical therapist practice: perceptions and applications. Phys Ther. 2009;89(2):125–35.

    Article  PubMed  Google Scholar 

  28. Potter K, Fulk GD, Salem Y, Sullivan J. Outcome measures in neurological physical therapy practice, part I: making sound decisions. J Neurol Phys Ther. 2011;35(2):57–64.

    Article  PubMed  Google Scholar 

  29. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 191–205.

    Google Scholar 

  30. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

    Article  CAS  PubMed  Google Scholar 

  31. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Mar St Med J. 1965;14:61–5.

    CAS  Google Scholar 

  32. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool in rehabilitation. Adv Clin Rehabil. 1987;1:6–18.

    CAS  PubMed  Google Scholar 

  33. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.

    Article  CAS  PubMed  Google Scholar 

  34. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996;5(1):139–50.

    Article  CAS  PubMed  Google Scholar 

  35. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. 2010;46(6):1033–40.

    Article  PubMed  Google Scholar 

  36. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2:175–84.

    Article  CAS  PubMed  Google Scholar 

  37. Keele KD. The pain chart. Lancet. 1948;2:6–8.

    Article  CAS  PubMed  Google Scholar 

  38. Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis. 1978;37(4):378–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277–99.

    Article  CAS  PubMed  Google Scholar 

  40. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method of the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.

    Article  CAS  PubMed  Google Scholar 

  41. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812.

    Article  Google Scholar 

  42. Ownsworth T, Hawkes A, Steginga S, Walker D, Shum D. A biopsychosocial perspective on adjustment and quality of life following brain tumor: a systematic evaluation of the literature. Disabil Rehabil. 2009;31:1038–55.

    Article  PubMed  Google Scholar 

  43. Khan F, Amatya B. Use of the international classification of functioning, disability and health (ICF) to describe patient-reported disability in primary brain tumour in an Australian community cohort. J Rehabil Med. 2013;45(5):434–45.

    Article  PubMed  Google Scholar 

  44. Langbecker D, Yates P. Primary brain tumor patients’ supportive care needs and multidisciplinary rehabilitation, community and psychosocial support services: awareness, referral and utilization. J Neurooncol. 2016;127(1):91–102.

    Article  PubMed  Google Scholar 

  45. Khan F, Amatya B, Ng L, Drummond K, Galea M. Multidisciplinary rehabilitation after primary brain tumour treatment. Cochrane Database Syst Rev. 2015;23(8):CD009509.

    Google Scholar 

  46. Meyers FJ, Linder J. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol. 2003;21:1412–5.

    Article  PubMed  Google Scholar 

  47. Bartolo M, Zucchella C, Pace A, Lanzetta G, Vecchione C, Bartolo M, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol. 2012;107(3):537–44.

    Article  PubMed  Google Scholar 

  48. Pace A, Metro G, Fabi A. Supportive care in neurooncology. Curr Opin Oncol. 2010;22:621–6.

    Article  PubMed  Google Scholar 

  49. Giordana MT, Clara E. Functional rehabilitation and brain tumour patients. A review of outcome. Neurol Sci. 2006;27:240–4.

    Article  CAS  PubMed  Google Scholar 

  50. Wolff G, Toborek M. Targeting the therapeutic effects of exercise on redox-sensitive mechanisms in the vascular endothelium during tumor progression. IUBMB Life. 2013;65(7):565–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Correa DD. Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep. 2010;10:232–9.

    Article  PubMed  Google Scholar 

  52. Back M, Back E, Kastelan M, Wheeler H. Cognitive deficits in primary brain tumours: a framework for management and rehabilitation. J Cancer Ther. 2014;5:74–81.

    Article  Google Scholar 

  53. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumors. Lancet Neurol. 2004;66:159–68.

    Article  Google Scholar 

  54. Giovagnoli AR. Investigation of cognitive impairments in people with brain tumors. J Neurooncol. 2012;108(2):277–83.

    Article  PubMed  Google Scholar 

  55. Martino J, Honma SM, Findlay AM, Guggisberg AG, Owen JP, Kirsch HE, et al. Resting functional connectivity in patients with brain tumors in eloquent areas. Ann Neurol. 2011;69(3):521–32.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, et al. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. J Neurooncol. 2014;116(2):373–9.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Ghumman S, Fortin D, Noel-Lamy M, Cunnane SC, Whittingstall K. Exploratory study of the effect of brain tumors on the default mode network. J Neurooncol. 2016;128(3):437–44.

    Article  PubMed  Google Scholar 

  58. Bahrami N, Seibert TM, Karunamuni R, Bartsch H, Krishnan A, Farid N, et al. Altered network topology in patients with primary brain tumors after fractionated radiotherapy. Brain Connect. 2017;7(5):299–308.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Gehrke AK, Baisley MC, Sonck ALB, Wronski SL, Feuerstein M. Neurocognitive deficits following primary brain tumour treatment: systematic review of a decade of comparative studies. J Neurooncol. 2013;115(29):135–42.

    Article  PubMed  Google Scholar 

  60. Day J, Gillespie DC, Rooney AG, Bulbeck HJ, Zienius K, Boele F, et al. Neurocognitive deficits and neurocognitive rehabilitation in adult brain tumours. Curr Treat Options Neurol. 2016;18(5):22.

    Article  PubMed  Google Scholar 

  61. Klein M, Duffau H, Hamer PD. Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol. 2012;108:309–18.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Piil K, Jarden M, Jakobsen J, Christensen KB, Juhler M. A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high- grade gliomas and their caregivers. BMJ Open. 2013;3(7):e003183.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Sterckx W, Coolbrandt A, Dierckx de Casterlé B, Van den Heede K, Decruyenaere M, Borgenon S, et al. The impact of a high-grade glioma on everyday life: a systematic review from the patient’s and caregiver’s perspective. Eur J Oncol Nurs. 2013;17(1):107–17.

    Article  PubMed  Google Scholar 

  64. Flechl B, Sax C, Ackerl M, Crevenna R, Woehrer A, Hainfellner J, et al. The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma. Radiother Oncol. 2017;125(2):228–33.

    Article  CAS  PubMed  Google Scholar 

  65. Meyers CA, Hess KR. Multifaceted end points in brain tumour clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol. 2003;5:89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Wilson BA. Neuropsychological rehabilitation. Ann Rev Clin Psychol. 2008;4:141–62.

    Article  Google Scholar 

  67. Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011;92(4):519–30.

    Article  PubMed  Google Scholar 

  68. Bergo E, Lombardi G, Pambuku A, Della Puppa A, Bellu L, D'Avella D, et al. Cognitive rehabilitation in patients with gliomas and other brain tumors: state of the art. Biomed Res Int. 2016;2016:3041824.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Chan V, Xiong C, Colantonio A. Patients with brain tumors: who receives postacute occupational therapy services? Am J Occup Ther. 2015;69(2):1–6.

    Article  Google Scholar 

  70. Richter A, Woernle CM, Krayenbühl N, Kollias S, Bellut D. Affective symptoms and white matter changes in brain tumor patients. World Neurosurg. 2015;84(4):927–32.

    Article  PubMed  Google Scholar 

  71. Molassiotis A, Wilson B, Brunton L, Chaudhary H, Gattamaneni R, McBain C. Symptom experience in patients with primary brain tumours: a longitudinal exploratory study. Eur J Oncol Nurs. 2010;14:410–6.

    Article  PubMed  Google Scholar 

  72. Rosenblum ML, Kalkanis L, Goldberg W, Rock J, Mikkelsen T, Remer S, et al. Odyssey of hope: a physician’s guide to communicating with brain tumor patient across the continuum of care. J Neurooncol. 2009;92:241–51.

    Article  PubMed  Google Scholar 

  73. Janda M, Steginga S, Langbecker D, Dunn J, Walker D, Eakin E. Quality of life among patients with a brain tumor and their carers. J Psychosom Res. 2007;63:617–23.

    Article  PubMed  Google Scholar 

  74. Schubart JR, Kinzie MB, Farace E. Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro Oncol. 2008;10(1):61–72.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Ford E, Catt S, Chalmers A, Fallowfield L. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol. 2012;14:392–404.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Fox S, Lantz C. The brain tumor experience and quality of life: a qualitative study. J Neurosci Nurs. 1998;30(4):245–52.

    Article  CAS  PubMed  Google Scholar 

  77. Sherwood PR, Cwiklik M, Donovan HS. Neurooncology family caregiving: review and directions for future research. CNS Oncol. 2016;5(1):41–8.

    Article  CAS  PubMed  Google Scholar 

  78. Wideheim AK, Edvardsson T, Pählson A, Ahlström G. A family’s perspective on living with a highly malignant brain tumor. Cancer Nurs. 2002;25(3):236–44.

    Article  PubMed  Google Scholar 

  79. Schmer C, Ward-Smith P, Latham S, Salacz M. When a family member has a malignant brain tumor: the caregiver perspective. J Neurosci Nurs. 2008;40(2):78–84.

    Article  PubMed  Google Scholar 

  80. Sherwood PR, Given BA, Doorenbos AZ, Given CW. Forgotten voices: lessons from bereaved caregivers of persons with a brain tumour. Int J Palliat Nurs. 2004;10(2):67–75.

    Article  PubMed  Google Scholar 

  81. McConigley R, Halkett G, Lobb E, Novak A. Caring for someone with high grade glioma: a time of rapid change for caregivers. Palliat Med. 2010;24(5):473–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rehabilitation, Neurorehabilitation Unit, HABILITA, Bergamo, Italy

    Michelangelo Bartolo

  2. Functional Recovery and Rehabilitation Unit, Neuromotor/Oncologic Sections, Fondazione Salvatore Maugeri, Pavia, Italy

    Isabella Springhetti

Authors
  1. Michelangelo Bartolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabella Springhetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelangelo Bartolo .

Editor information

Editors and Affiliations

  1. Department of Rehabilitation, Neurorehabilitation Unit, Habilita S.p.A., Zingonia/Ciserano, Bergamo, Italy

    Michelangelo Bartolo

  2. University and City of Health and Science, Department Neuro-Oncology, Turin, Torino, Italy

    Riccardo Soffietti

  3. Department of Medical Psychology, VU University Medical Center Department of Medical Psychology, Amsterdam, The Netherlands

    Martin Klein

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bartolo, M., Springhetti, I. (2019). Neurorehabilitation in Neuro-Oncology. In: Bartolo, M., Soffietti, R., Klein, M. (eds) Neurorehabilitation in Neuro-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-95684-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95684-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95683-1

  • Online ISBN: 978-3-319-95684-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation